Issue 42, 2010

Cyclen-hybrid compound captures copper to protect INS-1cells from islet amyloidpolypeptide cytotoxicity by inhibiting and lysing effects

Abstract

Human islet amyloid polypeptide (hIAPP) deposit is the hallmark of type 2 diabetes pathology. Here, we report that apo-cyclen, attached to a specific hIAPP recognition motif (NYGAIL), captured copper ions and became proteolytically active. This cyclen-NYGAIL-copper complex was able to interfere with hIAPP aggregation and cleave hIAPP. These activities rescued INS-1 cells from hIAPP induced cytotoxicity.

Graphical abstract: Cyclen-hybrid compound captures copper to protect INS-1 cells from islet amyloid polypeptide cytotoxicity by inhibiting and lysing effects

Supplementary files

Article information

Article type
Communication
Submitted
14 Jul 2010
Accepted
02 Sep 2010
First published
21 Sep 2010

Chem. Commun., 2010,46, 8023-8025

Cyclen-hybrid compound captures copper to protect INS-1 cells from islet amyloid polypeptide cytotoxicity by inhibiting and lysing effects

J. Hu, Y. Yu, W. Cui, C. Fang, W. Wu, Y. Zhao and Y. Li, Chem. Commun., 2010, 46, 8023 DOI: 10.1039/C0CC02555K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements